The American Red Cross has begun testing all blood, platelet and plasma donations for COVID-19 antibodies. Read More >

BioFlyte said on Tuesday that it has raised $1.25 million in seed funding, which the company said it will use to accelerate the development of its mass spectrometry-based biothreat detection device. The round was led by venture capital firm... Read More >

Kidney disease diagnostics firm RenalytixAI announced Friday it has received a clinical laboratory permit from the New York State Department of Health allowing the company to provide its KidneyIntelX test to residents of the state. The test... Read More >

HTG Molecular said on Thursday that it has signed three new European distribution agreements to promote its products and services in Nordic and Eastern Europe countries. The Tucson, Arizona-based firm signed agreements with Denmark-based Bi... Read More >

An international team led by investigators at the Max Planck Institute for the Science of Human History (MPI-SHH) and the National Museums of Kenya has uncovered population patterns going back thousands of years in sub-Saharan Africa, inclu... Read More >

Cue Health announced Wednesday that it has raised $100 million in Series C financing. Read More >

MilliporeSigma and 10x Genomics announced on Wednesday a collaboration on single-cell CRISPR screening workflows. The workflows will combine MilliporeSigmas CRISPR genome editing reagents with 10xs Feature Barcode assay to enable single-cel... Read More >

CareDx said on Wednesday that it has priced a planned $125 million public stock offering at $32 per share. The Brisbane, California-based molecular diagnostics firm said it will offer 3,906,250 shares of its common stock through the transac... Read More >

Researchers at Johns Hopkins University have developed a gene editing approach they call very fast CRISPR (vfCRISPR) that is capable of creating double-strand breaks (DSBs) in seconds, and at the submicrometer scale. During gene editing, it... Read More >

Roche subsidiary Foundation Medicine announced Friday it has acquired precision oncology firm Lexent Bio to help expand its liquid biopsy platforms and advance cancer care. Financial and other details of the deal were not disclosed. Lexent... Read More >